|
|
|
European Pharmaceutical Contractor
|
| Dr Jenny Gebhardt of BPI Service GmbH and Gloria Cenni of Bassilichi Spa describe the various standard validation processes available for use in pharmacovigilance projects
The German Pharmaceutical Industry Association has implemented a joint pharmacovigilance database, dubbed ‘BPIPheda’, to be used by multiple pharmaceutical firms to manage and electronically transmit case reports of adverse reactions in compliance with EU and international standards. This database, which is hosted on a central server system and accessed via an internet portal, allows each firm an individual secure subsection of the database to store and retrieve its own safety reports. Joined to this database is an ESTRI-gateway – a software program which allows the sending and receiving of safety reports within the EudraVigilance system, with a communication network with the EMEA’s gateway at its centre.
In addition to its core function of sending and receiving case reports, the database system also incorporates many administrative functions, such as queries and the generation of reports (such as Line Listings, CIOMS forms). The database system was validated in compliance with industry standards; however, validation activities were planned and executed using the critical process as a guide, which resulted in a clearer, more concise and more efficient validation documentation.
THE CRITICAL PROCESS
In systems which incorporate many different software components, validation procedures can become very complex. This is especially the case when the individual components are not programmed by the same provider or are to be integrated into a wholly new system. The interfaces between the different components and the individual system requirements of each component render validation activities which are restricted to each component in isolation impractical. Approaching system validation on a component-by-component level would not adequately show the function of the whole system, which is greater than the sum of its parts. |
Read full article from PDF >>
|
 |
 |
 |
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
Dr Jenny Gebhardt, Project Leader of Pharmacovigilance, is head of the pharmacovigilance department of the BPI Service GmbH, a subsidiary of the German Pharmaceutical Industry Association. Her responsibilities include the management and oversight of all pharmacovigilance projects run by the BPI Service. She also frequently appears in expert panels and seminars on topics surrounding pharmacovigilance. As a physician, Jenny has clinical and research experience in the fields of infectious diseases and gastroenterology, as well as an MSc in Clinical Trial Management.
Gloria Cenni has considerable experience in the pharmacovigilance field, culminating in her role as Bassilichi Spa Project Manager in the Eudra project for the European Commission, DG Enterprise and the European Medicinal Agency (EMEA). Over the last five years, Gloria has been involved in several projects commissioned to Bassilichi Spa from various EC institutions. In 2004, Gloria moved from the technical department, becoming Sales Manager with responsibility for the European industries market. She has activated a specific training programme for providing Bassilichi Spa’s customers with support in the process of joint validation. |
|
 |
 |
 |
|

 |
Industry Events |
 |
BIO-Europe Spring® 2012 — 6th International Partnering Conference
19-21 March 2012, Amsterdam RAI Convention Center, Amsterdam, The Netherlands
BIO-Europe Spring is the springtime counterpart to EBD Group’s flagship conference, BIO-Europe, and continues the tradition of providing life science companies with high caliber partnering opportunities. Featuring EBD Group’s sophisticated, web-based partnering system, partneringONE®, the event enables delegates to efficiently identify, meet and get partnerships started with companies across the life science value chain, from large biotech and pharma companies to financiers and innovative start-ups.
More info >> |
|
 |
News and Press Releases |
 |
Record sales of new de-blistering and leak testing equipment at packaging machinery manufacturer, Sepha Ltd
The packaging machinery manufacturer, Sepha Ltd, has reported record sales of its recently extended range of non-destructive leak testing equipment for the world's pharmaceutical packaging industry. With demand up across all major markets, the company says the increase will fund future R&D and enable it to bring forward future innovations aimed at reducing costs and driving quality for pharmaceutical manufacturers and contract packers.
More info >> |
|
|